Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Head & Neck
|
March 14, 2002
Functional status after primary surgical therapy for squamous cell carcinoma of the base of the tongue
Paul Friedlander, Salvatore Caruana, Bhuvanesh Singh, et al.
Oral Oncology
|
September 6, 2005
The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanisms
Jennifer Bolt, Quynh N Vo, Wan-Ju Kim, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
June 26, 2017
Liver transplantation in New Orleans: parity in a world of disparity?
Alison A Smith, Michael Darden, Zaid Al-Qurayshi, et al.
Surgery
|
December 7, 2016
Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer
Zakaria Y Abd Elmageed, Andrew B Sholl, Koji Tsumagari, et al.
Annals of Surgical Oncology
|
May 6, 2016
Metadherin Expression is Associated with Extrathyroidal Extension in Papillary Thyroid Cancer Patients
Robert F Moore, Andrew B Sholl, Laura Kidd, et al.
International Journal of Oncology
|
October 23, 2019
Tumor necrosis factor-α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial- and non-mitochondrial-dependent pathways
Denis Selimovic, Renate U Wahl, Emmanuelle Ruiz, et al.
International Journal of Oncology
|
April 30, 2026
[Corrigendum] Tumor necrosis factor‑α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial‑ and non‑mitochondrial‑dependent pathways
Denis Selimovic, Renate U Wahl, Emmanuelle Ruiz, et al.
Endocrine-Related Cancer
|
December 23, 2017
Bortezomib sensitizes thyroid cancer to BRAF inhibitor <i>in vitro</i> and <i>in vivo</i>
Koji Tsumagari, Zakaria Y Abd Elmageed, Andrew B Sholl, et al.
Journal of the American College of Surgeons
|
January 26, 2018
Prognostic Role of BRAF<sup>V600E</sup> Cellular Localization in Melanoma
Zakaria Y Abd Elmageed, Robert F Moore, Koji Tsumagari, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Head & Neck
|
March 14, 2002
Functional status after primary surgical therapy for squamous cell carcinoma of the base of the tongue
Paul Friedlander, Salvatore Caruana, Bhuvanesh Singh, et al.
Oral Oncology
|
September 6, 2005
The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanisms
Jennifer Bolt, Quynh N Vo, Wan-Ju Kim, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
June 26, 2017
Liver transplantation in New Orleans: parity in a world of disparity?
Alison A Smith, Michael Darden, Zaid Al-Qurayshi, et al.
Surgery
|
December 7, 2016
Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer
Zakaria Y Abd Elmageed, Andrew B Sholl, Koji Tsumagari, et al.
Annals of Surgical Oncology
|
May 6, 2016
Metadherin Expression is Associated with Extrathyroidal Extension in Papillary Thyroid Cancer Patients
Robert F Moore, Andrew B Sholl, Laura Kidd, et al.
International Journal of Oncology
|
October 23, 2019
Tumor necrosis factor-α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial- and non-mitochondrial-dependent pathways
Denis Selimovic, Renate U Wahl, Emmanuelle Ruiz, et al.
International Journal of Oncology
|
April 30, 2026
[Corrigendum] Tumor necrosis factor‑α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial‑ and non‑mitochondrial‑dependent pathways
Denis Selimovic, Renate U Wahl, Emmanuelle Ruiz, et al.
Endocrine-Related Cancer
|
December 23, 2017
Bortezomib sensitizes thyroid cancer to BRAF inhibitor <i>in vitro</i> and <i>in vivo</i>
Koji Tsumagari, Zakaria Y Abd Elmageed, Andrew B Sholl, et al.
Journal of the American College of Surgeons
|
January 26, 2018
Prognostic Role of BRAF<sup>V600E</sup> Cellular Localization in Melanoma
Zakaria Y Abd Elmageed, Robert F Moore, Koji Tsumagari, et al.
Page
of 6